1. Home
  2. UNM vs VTRS Comparison

UNM vs VTRS Comparison

Compare UNM & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unum Group

UNM

Unum Group

HOLD

Current Price

$78.41

Market Cap

12.4B

Sector

Finance

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$12.44

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNM
VTRS
Founded
1848
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4B
14.2B
IPO Year
1986
N/A

Fundamental Metrics

Financial Performance
Metric
UNM
VTRS
Price
$78.41
$12.44
Analyst Decision
Buy
Hold
Analyst Count
11
6
Target Price
$94.55
$11.50
AVG Volume (30 Days)
1.5M
8.6M
Earning Date
02-03-2026
02-26-2026
Dividend Yield
2.34%
3.87%
EPS Growth
N/A
N/A
EPS
5.18
N/A
Revenue
$13,068,000,000.00
$14,124,400,000.00
Revenue This Year
$3.51
N/A
Revenue Next Year
$3.16
$1.18
P/E Ratio
$15.20
N/A
Revenue Growth
2.13
N/A
52 Week Low
$66.81
$6.85
52 Week High
$84.48
$12.68

Technical Indicators

Market Signals
Indicator
UNM
VTRS
Relative Strength Index (RSI) 55.70 71.76
Support Level $75.90 $12.19
Resistance Level $79.19 $12.68
Average True Range (ATR) 1.40 0.27
MACD -0.05 -0.00
Stochastic Oscillator 56.26 79.28

Price Performance

Historical Comparison
UNM
VTRS

About UNM Unum Group

Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: